Health ❯ Healthcare ❯ Clinical Research

Phase 3 Trials

HOPE-3 Trial Randomized Controlled Trials Olatorepatide Eli Lilly's Orforglipron Patient Outcomes GRACE Trial STEP UP Trial EULAR 2025 Combination Therapy STEER and STRENGTH Studies

Xenon Presents Phase 3 Azetukalner Results and 48‑Month Data at American Academy of Neurology Meeting

The conference disclosures offer an early view of late‑stage results alongside long‑term follow‑up for a new KV7 therapy.

Single Daily Bictegravir–Lenacapavir Pill Matches Complex HIV Regimens in Phase III

FDA Issues Complete Response Letter for Corcept’s Relacorilant in Cushing’s-Related Hypertension

Roche’s Giredestrant Cuts Early Breast Cancer Recurrence 30% in Phase III Trial

FDA Approves One-Time Intrathecal Gene Therapy Itvisma for Older SMA Patients

FDA Approves Lynkuet, a Nonhormonal Pill for Menopausal Hot Flashes

J&J Myeloma Trial Stopped Early After Tecvayli–Darzalex Shows PFS and OS Benefit

FDA Opens Door to Reconsider Capricor’s Duchenne Cell Therapy Based on HOPE-3 Data

Ionis’ Olezarsen Slashes Triglycerides, Cuts Pancreatitis in Phase 3 Trials

Moderna Withdraws Flu-COVID Vaccine Application After FDA Requests More Data

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

Lenacapavir Injection Offers Breakthrough in HIV Prevention

Novo Nordisk's Oral Semaglutide Shows 14% Reduction in Heart Risks